Recruiting at 2 sites No phase Parkinson Disease (PD)

Parkinson Disease study: Robotic Apparel

Official title Robotic Apparel to Prevent Freezing of Gait in Parkinson Disease

ClinicalTrials.gov ID: NCT06602544

What this study is testing

What it's testing
The study wants to see if gentle mechanical help from a wearable robot can improve walking patterns and reduce episodes where feet feel stuck.
Who it's for
It is looking for adults who have Parkinson’s disease and experience freezing of gait.
What's involved
Participants will wear the robotic apparel while walking and may have a few tests to measure stride length and timing. The device provides low‑force assistance automatically.
Time commitment
The study lasts several weeks, with regular clinic visits and walking sessions to collect data.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 90

You may be able to join if

  • 18-90 years old
  • Self-reported Freezing of Gait due to PD
  • Score of 21 or higher on the cognitive screening test (Montreal Cognitive Assessment Score (MoCA))
  • Independent ambulation (with or without an assistive device, no physical assistance) for at least 20 meters
  • Able to understand, communicate, and be understood by study staff

You likely can't join if

  • More than 2 falls in the previous month, as a result of gait impairment (may enroll under clinician discretion)
  • Major surgery in the last 6 months that interferes with walking (may enroll under clinician discretion)
  • Gait deficits due to missing limbs
  • Experience chronic pain that interferes with walking ability (may enroll under clinician discretion)
  • Serious co-morbidities (unrelated to gait impairment) that may interfere with ability to participate in research (e.g.
  • No observable freezing-of-gait
See the full eligibility criteria
Who can join
  • 18-90 years old
  • Self-reported Freezing of Gait due to PD
  • Score of 21 or higher on the cognitive screening test (Montreal Cognitive Assessment Score (MoCA))
  • Independent ambulation (with or without an assistive device, no physical assistance) for at least 20 meters
  • Able to understand, communicate, and be understood by study staff
  • Provide HIPAA Authorization to allow communication with the participant's treating physician/provider for medical clearance (if deemed necessary by study clinical team) to verify self-reported medical history (if deemed...
  • Provide informed consent
  • Ability to participate in 8 research study visits
What rules you out
  • More than 2 falls in the previous month, as a result of gait impairment (may enroll under clinician discretion)
  • Major surgery in the last 6 months that interferes with walking (may enroll under clinician discretion)
  • Gait deficits due to missing limbs
  • Experience chronic pain that interferes with walking ability (may enroll under clinician discretion)
  • Serious co-morbidities (unrelated to gait impairment) that may interfere with ability to participate in research (e.g.
  • No observable freezing-of-gait

The study team makes the final eligibility decision.

Where it is enrolling

  • Allston, Massachusetts, United States
  • Boston, Massachusetts, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Allston, Massachusetts, United States; Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.